Page thématique

Veterinary medicine - ANMV

The French Agency for Veterinary Medicinal Products (ANMV), within ANSES, is the Competent Authority in France for risk assessment and management with regard to veterinary medicinal products.

In this capacity, the Government was keen for the ANMV to strive for constant improvement of its services with a view to protecting public health as well as the health and welfare of animals.

To this end, the ANMV must enforce the current applicable legal provisions in an independent, competent and impartial manner. Click here to find out more about the Agency’s history.

The ANMV is located in Javené, near Fougères (Ille-et-Vilaine) and has 80 staff members, mainly specialised scientists.

 

 

 

 

Declaring an adverse effect that may be due to a veterinary medicinal product (in French)

Sector professionals

List of veterinary pharmaceutical manufacturers and wholesalers (in French)

 

Marketing authorization (AMM) no./National Working Group (GTIN) code correspondence table (in French)

News

Procedures for reporting veterinary medicinal products stockouts
23/02/2024
News

Procedures for reporting veterinary medicinal products stockouts

The issue of medicinal products supply disruptions is a major topic for both animal and human health. In veterinary medicine, the holders or their representative (responsible for placing on the market) are obliged to report to Anses any risk of out-of-stock of a veterinary medicinal product which could lead to a risk to human health, animal health or animal welfare.
Anses participates in EU4Health Joint Action EU4H11
26/01/2024
News

Anses participates in EU4Health Joint Action EU4H11

EU4H11 (Joint Action on quality of medicines and implementation of the pharmaceutical legislation/strategy) is part of the EU4Health programme funded by the European Commission. The total budget of this Joint Action amounts to more than 3 million EUR, 80% of the costs will be co-financed by the European Commission. The project aims at strengthening capacities of EU/EEA GMP/GDP inspectorates in the global vision of mutual reliance of inspection data to better ensure quality of medicinal products and protection of Public Health.
Determination of the annual coefficient for the revaluation of taxes
01/12/2023
News

Determination of the annual coefficient for the revaluation of taxes

As part of its tasks relating to the assessment and risk management of veterinary medicinal products, ANSES collects taxes and fees. Taxes, with the exception of the annual tax indexed to the turnover of veterinary medicinal products, are revalued annually.
Antimicrobial resistance in animal health: 2023 review
17/11/2023
News

Antimicrobial resistance in animal health: 2023 review

ANSES’s work contributes to the fight against antimicrobial resistance. To mark World Antibiotic Awareness Week, the Agency is publishing the data collected in 2022 from: the monitoring of sales of veterinary medicinal products containing antimicrobials the French surveillance network for antimicrobial resistance in pathogenic bacteria of animal origin (Resapath) the European scheme for monitoring antimicrobial resistance in the food chain The Agency is also offering another look at its expert appraisal work on the transmission of antibiotic-resistant bacteria from animals to humans.
Head lice treatments: never use products for animals on children
Une enfant se faisant coiffer
11/10/2023
News

Head lice treatments: never use products for animals on children

On 2 October 2023, ANSES received a report involving the case of a young girl who was hospitalised in serious condition following the use of insecticides intended for treating parasites in cattle. Every year, the Agency is informed of cases where antiparasitics intended for animals are used to treat head lice in children. It reiterates that antiparasitic treatments for animals should never be used on human beings, especially children.
ANMV webinar on veterinary medicinal products for exotic pets
Webinaire de l’ANMV sur les médicaments vétérinaires destinés aux nouveaux animaux de compagnie
08/09/2023
News

ANMV webinar on veterinary medicinal products for exotic pets

Veterinary medicinal products which are intended for an exhaustive list of species kept only as pets : aquarium or pond animals, ornamental fish, apartment birds, travelling pigeons, terrarium animals, small rodents, ferrets and rabbits benefit from a simplified marketing procedure.
Signal detection
radio
03/07/2023
News

Signal detection

Regulation (EU) 2019/6 establishes an EU-wide pharmacovigilance system led by the European Medicines Agency (EMA) in collaboration with Member States for all veterinary medicinal products authorised in at least one EU country. The entry into force of this Regulation on 28 January 2022 brought a change of approach to pharmacovigilance which is now based on a signal detection process. This system allows active and continuous monitoring of pharmacovigilance data in order to detect potential safety problems early. For more information
Antiparasitics containing fipronil are toxic to rabbits
Lapin
20/06/2023
News

Antiparasitics containing fipronil are toxic to rabbits

Antiparasitics containing fipronil account for nearly one-third of adverse drug reactions reported in pet rabbits. These products, intended for use in dogs and cats, should not be administered to rabbits.
ANSES inspections for veterinary medicines recognised by US FDA
Europe USA
15/06/2023
News

ANSES inspections for veterinary medicines recognised by US FDA

On 30 May 2023, the European Union (EU) and the United States made significant progress towards mutual recognition of inspections of manufacturers of chemical veterinary medicinal products.
Avian influenza: three vaccination scenarios for poultry
elevage de canards
06/04/2023

Avian influenza: three vaccination scenarios for poultry

Health crises caused by avian influenza have been recurring and growing in scale, which means that preventive measures on French poultry farms need to be reinforced. The vaccination of poultry is a possible option that is being considered to supplement the biosecurity measures already in place on these farms. To help the public authorities establish a vaccination strategy that could be implemented as early as autumn 2023, ANSES is proposing three preventive vaccination scenarios. They aim to protect poultry sectors and limit the spread of the virus by determining the types of farms and the species to be vaccinated as a priority, depending on the available vaccination resources.
Be careful before giving human medication to an animal
Un chien auquel on donne des médicaments
20/02/2023

Be careful before giving human medication to an animal

Paracetamol and aspirin can be fatal for our pets. Other medication intended for humans can cause poisoning in animals. Below we review the most common situations and issue some recommendations you should keep in mind before giving these medicines to an animal.
Changes in the amount of taxes and fees
20/01/2023
News

Changes in the amount of taxes and fees

As part of its tasks relating to the assessment and risk management of veterinary medicinal products, ANSES collects taxes and fees. The taxes, with the exception of the annual fee indexed to the turnover of veterinary medicinal products, are revalued annually. The services provided for in the ANSES catalogue are also upgraded.

Decryption

ANSES's activities in the area of antimicrobial resistance and veterinary antimicrobials
Soin d'un porcelet
29/11/2022

ANSES's activities in the area of antimicrobial resistance and veterinary antimicrobials

The multiplication of bacterial strains that are resistant to antibiotics calls into question the efficacy of these treatments. The issue of antimicrobial resistance presents a major challenge for both human and animal health. ANSES carries out several missions in this area relating to animal health, food and the environment.
Eleven questions on antimicrobial resistance in animal health
Antibiorésistance
29/11/2022

Eleven questions on antimicrobial resistance in animal health

Antimicrobial resistance is a major issue for both human and animal health. The emergence and spread of bacterial strains that are resistant to antibiotics call into question the efficacy of these treatments. Preserving their efficacy is therefore a genuine public health challenge, requiring an integrated approach according to the One Health concept covering both humans and animals.
Antimicrobial resistance
Head lice: never use animal treatments on children
Parent peignant sa fille ayant des poux
30/08/2022

Head lice: never use animal treatments on children

Every year, cases of use of antiparasitic products intended for pets to treat head lice in children are reported. The Agency emphasises that antiparasitic treatments, insecticides or acaricides for pets should never be used on human beings, especially children.
Antimicrobial resistance: a major issue for animals and humans
Antibioresistance
08/01/2021

Antimicrobial resistance: a major issue for animals and humans

Antimicrobial resistance is a major issue for both human and animal health. The emergence and spread of antibiotic-resistant bacterial strains call into question the efficacy of these treatments. Preserving the efficacy of antibiotics is therefore a genuine public health challenge, requiring an integrated approach according to the One Health concept covering both humans and animals.
The proper use of ectoparasiticides in domestic animals
13/04/2018

The proper use of ectoparasiticides in domestic animals

External parasites can cause serious illnesses in animals, or even lead to diseases that are transmissible to humans. To control and/or prevent these diseases, a range of veterinary medicinal products are available.
ANSES: a brief outline
30/07/2015

ANSES: a brief outline

Created on 1 July 2010, the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) is an independent scientific body which performs its risk assessment, reference and research activities in the fields of food safety and animal and plant health. Its core activity is the assessment of health risks in order to enable the public authorities to make informed decisions and in so doing to help ensure the health and safety of of the population both in its working and consumer activities
Head lice treatments
18/05/2015

Head lice treatments

Antiparasitics, insecticides and anti-mite treatments intended for pets should never be used on humans, especially children. Veterinary medicinal products obtain marketing authorisation (MA) prior to marketing based on a risks vs benefits assessment for the animal they are to be used on. If the risks for humans have been identified and evaluated, it is only with regard to the risks for individuals who handle or administer the products.
ANSES laboratories
Laboratoires
15/02/2013

ANSES laboratories

ANSES has a network of nine reference and research laboratories located throughout France, close to industry. These laboratories operate in three main areas: animal health and welfare, food safety (chemical and microbiological) and plant health. They are internationally recognised in their respective fields of expertise: epidemiology, microbiology and antimicrobial resistance, toxins and physico-chemical contaminants. Thanks to their work in providing expertise, epidemiological monitoring, alerts and scientific and technical assistance, they play a vital role in understanding various threats and in collecting data from the network of accredited laboratories.

Publications

Document PDF
Date de mise en ligne
04/12/2023
Numéro de saisine
Pharmacovigilance2022
Document PDF
Date de mise en ligne
13/01/2023
Numéro de saisine
Antibiotiques2021-GB
Document PDF
Date de mise en ligne
19/12/2022
Numéro de saisine
Pharmacovigilance2021
Document PDF
Date de mise en ligne
09/02/2022
Numéro de saisine
Antibiotiques2020